Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 464

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 464
---
 Value Measurements**

The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The following table presents the Company’s financial assets that are measured at fair value on a recurring basis and the level of inputs used in such measurements (in thousands):

|                                     |     | June 30, 2025 |   |     |                                         |   |     |                                            |   |     |                                        |   |
|:------------------------------------|:----|:--------------|--:|:----|:----------------------------------------|--:|:----|:-------------------------------------------|:--|:----|:---------------------------------------|:--|
|                                     |     | Balance       |   |     | Quoted Prices inActive Markets(Level 1) |   |     | Significant OtherObservableInputs(Level 2) |   |     | SignificantUnobservableInputs(Level 3) |   |
| Assets                              |     |               |   |     |                                         |   |     |                                            |   |     |                                        |   |
| Money market funds                  |     | $             | 6 |     | $                                       | 6 |     | $                                          | — |     | $                                      | — |
| Total assets measured at fair value |     | $             | 6 |     | $                                       | 6 |     | $                                          | — |     | $                                      | — |

<div align='center'>F-93</div>

|                                     |     | December 31, 2024 |   |     |                                         |   |     |                                            |   |     |                                        |   |
|:------------------------------------|:----|:------------------|--:|:----|:----------------------------------------|--:|:----|:-------------------------------------------|:--|:----|:---------------------------------------|:--|
|                                     |     | Balance           |   |     | Quoted Prices inActive Markets(Level 1) |   |     | Significant OtherObservableInputs(Level 2) |   |     | SignificantUnobservableInputs(Level 3) |   |
| Assets                              |     |                   |   |     |                                         |   |     |                                            |   |     |                                        |   |
| Money market funds                  |     | $                 | 6 |     | $                                       | 6 |     | $                                          | — |     | $                                      | — |
| Total assets measured at fair value |     | $                 | 6 |     | $                                       | 6 |     | $